Issues
- Current Issue
- Special Issues
Viewpoints
Education
Spotlight
News
Topic Compilations
On Location
Multimedia
- Sound Bites
- Meeting Coverage

Search

ASH Home
About ASH Clinical News
Authors
Advertising
Subscribe
Contact Us
eNewsletters

Cookie Settings

LOG IN

Welcome! Log into your account

Forgot your password?

Recover your password

ASH Clinical News

Issues
- All Current Issue Special Issues
  
  March 2021 Special Edition
  
  March 2021 Volume 7 Issue 4
  
  February 2021 Volume 7 Issue 3
  
  Mid-January 2021 Annual Meeting Edition
Viewpoints
Education
Spotlight
News
Topic Compilations
On Location
Multimedia
- Sound Bites
- Meeting Coverage

Generic selectors

Exact matches only

Exact matches only

Search in title

Search in title

Search in content

Search in content

Search in excerpt

Search in posts

Search in posts

Search in pages

Search in pages

Steven Pavletic, MD

Steven Pavletic, MD

Senior Clinician, Immune Deficiency Cellular Therapy Program, National Cancer Institute

Advertisement

Current Issue

March 2021 Volume 7 Issue 4

Monday, March 1, 2021

This issue examines blood services across the globe, the repercussions of increased patient access to medical information, and more.

Block title

Crizotinib Approved for Relapsed/Refractory Systemic ALCL

Monday, March 1, 2021

Daratumumab and Hyaluronidase-fihj Approved for Light Chain Amyloidosis

Monday, March 1, 2021

Remembering Art Nienhuis, Thomas Edgington, and more

Monday, March 1, 2021

Charting the Myeloma Immunotherapy Landscape

Monday, March 1, 2021

Older Age, Pre-Existing Comorbidities Increase Poor Outcomes in Patients With SCD and COVID-19

Monday, March 1, 2021

Recent Posts

Crizotinib Approved for Relapsed/Refractory Systemic ALCL
Daratumumab and Hyaluronidase-fihj Approved for Light Chain Amyloidosis
Remembering Art Nienhuis, Thomas Edgington, and more
Charting the Myeloma Immunotherapy Landscape

Meeting Coverage

Researchers Validate Burkitt Lymphoma Prognostic Index

Monday, March 1, 2021

Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL

Monday, March 1, 2021

Editor's Corner

Editor’s Corner: Healing Our Invisible Wounds

Monday, March 1, 2021

Editor’s Corner: A Period Piece

Monday, February 1, 2021

2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545

ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store

Copyright © 2020 by American Society of Hematology

Contact Us | Terms of Service | Privacy Policy